Pmv Pharmaceuticals Inc Working Capital to Net Assets Ratio
Pmv Pharmaceuticals Inc working capital to net assets ratio. Pmv Pharmaceuticals Inc (PMVP) has a Working Capital to Net Assets ratio of 99.1% as of June 2026. Working capital of $70.84 Million (current assets of $81.41 Million minus current liabilities of $10.57 Million) is measured against net assets of $71.50 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Pmv Pharmaceuticals Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Pmv Pharmaceuticals Inc (2018–2025)
Working capital to net assets ratio of Pmv Pharmaceuticals Inc from 2018 to 2025. This chart shows how Pmv Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2018 to 2025. As of June 2026, the ratio stands at 99.1%, reflecting working capital of $70.84 Million against net assets of $71.50 Million USD. See operational self-sufficiency of Pmv Pharmaceuticals Inc to measure how many days the company can operate on defensive assets alone.
Pmv Pharmaceuticals Inc Working Capital to Net Assets Ratio by Year (2018–2025)
Pmv Pharmaceuticals Inc working capital to net assets ratio by year from 2018 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Pmv Pharmaceuticals Inc from 2018 to 2025, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of Pmv Pharmaceuticals Inc.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 99.1% | $103.81 Million | $104.71 Million | $115.23 Million | $11.41 Million | ▲ +7.5 pp |
| 2024 | 91.6% | $161.29 Million | $176.08 Million | $175.66 Million | $14.37 Million | ▲ +5.9 pp |
| 2023 | 85.7% | $193.38 Million | $225.69 Million | $207.41 Million | $14.03 Million | ▼ -10.3 pp |
| 2022 | 96.0% | $236.17 Million | $246.03 Million | $247.01 Million | $10.83 Million | ▲ +2.3 pp |
| 2021 | 93.7% | $289.07 Million | $308.56 Million | $301.29 Million | $12.22 Million | ▼ -6.1 pp |
| 2020 | 99.8% | $358.35 Million | $359.12 Million | $364.76 Million | $6.41 Million | ▲ +238.2 pp |
| 2019 | -138.4% | $97.57 Million | $-70.47 Million | $102.09 Million | $4.52 Million | ▼ -8.6 pp |
| 2018 | -129.8% | $59.91 Million | $-46.14 Million | $62.24 Million | $2.33 Million | — |